Noltrex^®Vet has become well integrated into the case management of a variety of osteoarthritis (OA) cases seen daily. This is certainly true of cases where horses have had less than an ideal response to more conventional therapies where clinicians choose Noltrex^®Vet to provide a more reliable outcome in advanced case management.

Given that Noltrex^®Vet has been proven to provide superior lubrication when compared to the hyaluronic acids (HA) used in equine practice , its ability to aggregate over cartilage defects as well as its longer residence time in the joint, it makes sense we are now seeing the adoption of Noltrex^®Vet use earlier in the management of OA. Using the product earlier enables the use of lower volumes of Noltrex^®Vet, especially when used in combination with standard anti-inflammatory agents such as steroids. The use of lower volumes, in cases where this is appropriate, also saves money and thus is more accessible in a greater number of cases!

Noltrex^®Vet is also the only polyacrylamide gel to be safely resorbed and completely removed from the joint and synovium over time and thus is safe to re-inject as needed.

Lower volume recommendations in the management of early disease cases and more conventional post-injection guidelines are defined within our NEW User Guide.